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Sensory Nerves Determine the Pattern
of Arterial Differentiation and
Blood Vessel Branching in the Skin
often run along larger blood vessels, reflecting their
need for oxygen and nutrients, as well as their physiolog-
ical control of vaso-constriction and -dilation (reviewed
in Burnstock and Ralevic, 1994). This intimate neuro-
vascular association and functional interaction raises
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California Institute of Technology the question of whether the branching patterns of these
two systems are ontogenetically and/or mechanistically1201 E. California Boulevard
Pasadena, California 91125 related (reviewed in Shima and Mailhos, 2000). On the
one hand, the branching pattern of blood vessels could3 Max Delbru¨ck Center for Molecular Medicine
13125 Berlin determine that of nerves, or vice versa. On the other
hand, the branching of both systems could be indepen-Germany
4 Department of Biochemistry dently controlled by common cues located in sur-
rounding tissue.and Molecular Biology
Graduate School of Medicine Evidence that the patterning of nerve and blood vessel
branching is interdependent is extremely limited. EarlyUniversity of Tokyo
Bunkyo-ku, Tokyo 113-0033 studies in embryonic chick limb skin using silver staining
to reveal the pattern of nerves and India ink injectionsJapan
to reveal that of blood vessels indicated that major nerve
fibers and large vessels are in reproducible alignment
(Martin and Lewis, 1989). This alignment evidently doesSummary
not reflect blood vessel-mediated axon guidance, be-
cause the initial pattern of nerve fiber arborization isNerves and blood vessels are branched structures,
but whether their branching patterns are established topographically unrelated to the pattern of blood vessel
branching at the time the nerves first invade the skinindependently or coordinately is not clear. Here we
show that arteries, but not veins, are specifically aligned (Martin and Lewis, 1989).
The question of whether nerves are required to estab-with peripheral nerves in embryonic mouse limb skin.
Mutations that eliminate peripheral sensory nerves or lish the branching pattern of blood vessels was ad-
dressed by using UV irradiation to locally ablate theSchwann cells prevent proper arteriogenesis, while
those that disorganize the nerves maintain the align- peripheral nervous system (PNS) in chick embryos (Mar-
tin and Lewis, 1989). The trajectory of large vessels inment of arteries with misrouted axons. In vitro, sensory
neurons or Schwann cells can induce arterial marker such aneurogenic limbs was surprisingly unperturbed
by this manipulation, suggesting that the spatial organi-expression in isolated embryonic endothelial cells, and
VEGF164/120 is necessary and sufficient to mediate this zation of nerve fibers and blood vessels is independently
controlled by common signals in the overlying skin. Itinduction. These data suggest that peripheral nerves
provide a template that determines the organotypic was not clear, however, whether the pattern of smaller-
diameter vessel branching was affected by the absencepattern of blood vessel branching and arterial differen-
tiation in the skin, via local secretion of VEGF. of nerves, because this pattern is less well defined and
therefore perturbations in it are more difficult to detect
(Martin and Lewis, 1989).Introduction
Here we have investigated the influence of the nervous
system on blood vessel development in the embryonicThe blood vessels and capillaries of the circulatory sys-
tem display an intricate pattern of branching that serves mouse limb skin, using genetic methods to eliminate or
disorganize peripheral nerves. To assay the effects ofto maximize the vascular surface area in contact with
surrounding tissue. This branching pattern is estab- such manipulations on the development of blood ves-
lished during a remodeling process called angiogenesis sels, we have examined the expression of artery-specific
that follows the initial assembly of primitive capillaries markers, such as ephrinB2 (Adams et al., 1999; Gerety
from individual endothelial cells by vasculogenesis (re- et al., 1999; Wang et al., 1998). We find that arteries
viewed in Risau and Flamme, 1995). In recent years, a are preferentially aligned with nerves and follow their
great deal has been learned about the molecular control branching pattern, while veins are not. In mutant em-
of angiogenesis (reviewed in Folkman and D’Amore, bryos lacking sensory nerves, arteries fail to properly
1996; Gale and Yancopoulos, 1999; Yancopoulos et al., differentiate, while in those containing disorganized
2000). What is not clear, however, is whether the pattern nerves the trajectory of blood vessel branching is altered
of peripheral blood vessel branching is self-organized to follow the nerve. In vitro functional assays and corre-
by endothelial cells, or whether it is determined by struc- lated in vivo data suggest that the expression of arterial
tures extrinsic to the cardiovascular system. markers in nerve-associated vessels may be controlled
Like blood vessels, peripheral nerves are highly by local secretion of VEGF from sensory nerve fibers,
branched structures. In adult peripheral tissues, nerves Schwann cells, or both. These data suggest that local
signals provided by organized tissue subcomponents,
such as nerve fibers, may provide a template that deter-5 Correspondence: wuwei@caltech.edu
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mines the organotypic patterning of arteriogenesis and
angiogenic remodeling.
Results
Peripheral Nerves Associate Preferentially
with Arterial Vessels in Limb Skin
In embryonic chick limb skin, some blood vessels are
associated with nerves, while others are not (Martin and
Lewis, 1989). We sought to determine whether this het-
erogeneity reflects random variation or, instead, the de-
terministic behavior of an identifiable subset of blood
vessels. As a first step, we examined the relationship
of arteries and veins to nerves in mouse limb skin, using
lacZ reporter strains to detect expression of ephrinB2
(arteries) or EphB4 (veins) (Gerety et al., 1999; Shin et
al., 2001; Wang et al., 1998), together with antibodies
to neurofilament (2H3) and PECAM-1, a pan-endothelial
marker. Whole-mount immunohistochemical analysis in
embryonic limb skin at E15.5 revealed that peripheral
nerves associated preferentially with arterial vessels
(Figures 1A–1F and 1M, arrows and open arrowheads;
see Supplemental Figure S1 at http://www.cell.com/cgi/
content/full/109/6/693/DC1). By contrast, no specific
association between peripheral nerves and veins was
observed (Figures 1G–1L and 1N, open arrows and ar-
rowheads). The association of arterial vessels with pe-
ripheral nerves did not appear to reflect a direct, intimate
attachment, but rather a looser alignment (Figures 1C
and 1M, arrows and open arrowheads).
Blood Vessel/Nerve Association Coincides with
the Induction of Arterial Marker Expression
The observed alignment of arteries and peripheral
nerves raised the question of whether arterial differentia-
tion follows or precedes nerve association. To distin-
guish between these possibilities, we analyzed the time
course of blood vessel/nerve association in relation to
the appearance of the arterial markers ephrinB2, Neu-
ropilin1 (NP1), and Connexin40 (CX40). NP1 is a core-
ceptor for VEGF164 (Kawasaki et al., 1999; Soker et al.,
1998) and is preferentially expressed by arteries in chick
(Moyon et al., 2001) as well as in mouse embryos (Y.M.,
Figure 1. Arteries Are Specifically Aligned with Peripheral NervesD.S., and D.J.A., unpublished data). CX40 is a gap junc-
in Limb Skin
tion protein (van Kempen and Jongsma, 1999) that is
Forelimb skin of E15.5 ephrinB2taulacZ/ (A–F and M) or EphB4taulacZ/
specifically expressed in the dorsal aorta as well as in (G–L and N) heterozygous embryos is shown. Whole-mount triple
smaller arterial vessels in mouse embryos (D.S., Y.M., immunofluorescence confocal microscopy with antibodies to the
and D.J.A., unpublished data). pan-endothelial marker PECAM-1 (blue), neurofilament (2H3; green),
and -galactosidase (-gal, red) reveals that 2H3 peripheral nervesA primary capillary plexus is established in the mouse
(C and F, open arrowheads) follow ephrinB2taulacZ/PECAM-1-express-limb by E11. Within 24 hr, peripheral nerves have invaded
ing arterial vessels (C and F, arrows) in ephrinB2taulacZ/ heterozygousthe skin (data not shown). At E13.5, no association be-
embryos. In contrast, there is no association between 2H3 periph-
tween nerves and blood vessels was yet evident (Figure eral nerves (I and L, arrowheads) and EphB4taulacZ/PECAM-1-
2A), and no vascular expression of the three arterial expressing venous vessels (I and L, open arrows) in EphB4taulacZ
markers was detectable (Figures 2D, 2J, and 2P). How- heterozygous embryos.
(M and N) Higher-magnification view of limb skin from E15.5ever, NP1 expression was observed in the nerves (Figure
ephrinB2taulacZ/ or EphB4taulacZ/ embryos. Note that arteries are2J, arrowheads), reflecting its role in axon guidance (re-
aligned, but not tightly associated, with nerves. Scale bars areviewed in Kolodkin, 1998). By E14.5, vascular remodel-
100 m.
ing had occurred, and many vessels were associated
with nerves (Figures 2B and 2H, arrows), which had
downregulated NP1. At this stage, arterial markers were ers (Figures 2B, 2E, 2H, 2K, 2N, and 2Q, open arrow-
heads). By E15.5, however, most nerve-associatedfirst detectable in some nerve-associated vessels (Fig-
ures 2E, 2K, and 2Q, arrows). Some smaller vessels large- and medium-sized vessels expressed ephrinB2
(Figures 2C and 2F, arrows), and many expressed NP1associated with nerves did not yet express arterial mark-
Patterning of Arteriogenesis by Peripheral Nerve
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Figure 2. Nerve Association Precedes Arte-
rial Differentiation
Whole-mount triple immunofluorescence con-
focal microscopy was performed with anti-
bodies to the arterial markers ephrinB2 (indi-
cated by -gal staining) (A–F, red), NP1 (G–L,
red), or CX40 (M–R, red) together with anti-
bodies to PECAM-1 (A–C, G–I, and M–O, blue)
and neurofilament (2H3) (A–C, G–I, and M–O,
green) at the indicated developmental ages.
Note that an association between 2H3 pe-
ripheral nerves and arterial vessels was ob-
served at E14.5 to E15.5 but not E13.5. NP1
expression at E13.5 is seen in peripheral
nerves but not in blood vessels (G and J,
arrowheads). Scale bars are 100 m.
and CX40 (Figures 2I, 2L, 2O, and 2R, arrows). Taken viewed in Folkman and D’Amore, 1996). We were inter-
ested to know whether smooth muscle association withtogether, these data suggest that arterial markers do
not become expressed until after blood vessels associ- arteries occurs concomitantly with, or following, nerve
association and arterial differentiation of endothelialate with nerves in limb skin.
cells. To address this question, we examined the loca-
tion of smooth muscle cells in the limb skin from E13.5Blood Vessel/Nerve Association Precedes
the Migration and/or Differentiation through E15.5. At E13.5, SMA smooth muscle cells
not yet associated with blood vessels (or had associatedof Smooth Muscle Cells
Association of smooth muscle cells with endothelial but still remained undifferentiated; Figures 3A and 3D).
By E14.5, vascular SMA cells were detectable, butcells is an important step in vascular remodeling (re-
Cell
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Figure 3. Blood Vessel/Nerve Association
and Arterial Marker Expression Precedes
Smooth Muscle Cell Differentiation
(A–F) Whole-mount triple immunofluores-
cence confocal microscopy was performed
with antibodies to the smooth muscle cell
marker, SMA (A–F, red), in addition to
PECAM-1 (A–C, blue) and 2H3 (A–C, green),
at the indicated developmental ages. Note
that by E15.5, SMA smooth muscle cell
coverage occurred around PECAM-1 ves-
sels adjacent to 2H3 nerves (arrows). By
E14.5, blood vessel/nerve association could
be seen before smooth muscle cell coverage
(B and E, open arrowheads).
(G–L) Arterial marker expression such as
ephrinB2 (indicated by -gal staining) (G and
H, green) and NP1 (J and K, green) is detect-
able before SMA smooth muscle cell cov-
erage (G, I, J, and L, red, open arrowheads).
Scale bars are 100 m.
only in larger nerve-associated vessels (Figures 3B and zygous mutants lack peripheral sensory nerves (Ma et
al., 1999), whereas Phox2b homozygous mutants lack3E, arrows). However, not all nerve-associated vessels
had SMA cells at this time point (Figures 3B and 3E, peripheral autonomic nerves (Pattyn et al., 1999). A com-
parison of the expression of the sensory markers sub-open arrowheads). By E15.5, SMA cell coverage had
extended further into the capillary network, on smaller stance P, IB4 lectin, and trkA with the sympathetic mark-
ers tyrosine hydroxylase and dopamine  hydroxylasebranches as well (Figures 3C and 3F, arrows). However,
the expression of ephrinB2 and NP1 at this stage ap- revealed that only sensory nerves were present in the
limb skin between E13.5 and E15.5 (data not shown).peared to extend further into the smaller vessel
branches than did that of SMA (Figures 3G–3I and Consistent with these data, Phox2b homozygous mu-
tants showed no peripheral nerve defects in the limb skin3J–3L, open arrowheads). These results indicate that
smooth muscle cells associate with vessels (or differen- at these stages (data not shown). In contrast, Ngn1/;
Ngn2/ embryos showed a virtually complete absencetiate) only after such vessels have become aligned with
nerves and begun to express arterial markers. Taken of peripheral nerves and associated Schwann cells in
the limb skin, as determined by staining for neurofila-together, these observations suggest that arteriogene-
sis—the molecular differentiation of arterial endothelial ment and the glial marker Brain Fatty Acid Binding Pro-
tein (BFABP), respectively (Figures 4A and 4B, opencells and associated smooth muscle cells—is initiated
in smaller vessels only after they associate with nerves. arrowheads; Kurtz et al., 1994).
In the absence of peripheral sensory nerves, some
vascular remodeling of large and small vessels occurredDefective Arteriogenesis in the Absence
of Peripheral Nerves (Figure 4C versus 4D, arrows). However, the progressive
branching pattern was disrupted so that large-diameterTo determine whether peripheral nerves are required
for arteriogenesis, we took advantage of mutations that vessels branched directly into small-diameter vessels
with fewer intermediate-size branches. In addition to thiscause severe defects in peripheral nerve development.
Neurogenin1/Neurogenin2 (Ngn1/Ngn2) double homo- altered morphology, the expression of arterial markers
Patterning of Arteriogenesis by Peripheral Nerve
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Figure 4. Defective Arterial Differentiation in the Absence of Peripheral Nerves
(A–D) Whole-mount triple immunofluorescence confocal microscopy was performed with antibodies to the Schwann cell marker, BFABP (A
and B, red), as well as PECAM-1 (A–D, blue) and 2H3 (A and B, green), in Ngn1/; Ngn2/ double homozygous mutants (B and D) or wild-
type littermates (A and C) at E15.5. Note that Ngn1/; Ngn2/ mutants have no peripheral nerves and associated BFABP Schwann cells (A
versus B, open arrowheads). In addition, defective patterning of vascular remodeling is seen in Ngn1/; Ngn2/ mutants (C versus D, arrows).
(E–H) Triple labeling for CX40 (E–H, red), PECAM-1 (E and F, blue), and 2H3 (E and F, green) in Ngn1/; Ngn2/ mutants (F and H) or wild-
type littermates (E and G) at E15.5.
(I–N) Double labeling with NP1 (I–N, red) and PECAM-1 (I–L, blue) in Ngn1/; Ngn2/ mutants (J, L, and N) or wild-type littermates (I, K, and
M) at E15.5. Close-up (K–N) shows the boxed region in (I) and (J). The expression of arterial markers such as CX40 and NP1 was downregulated
in Ngn1/; Ngn2/ mutants (E versus F, G versus H, K versus L, and M versus N, red, arrows).
(O–R) Double labeling for SMA (O–R, red) and PECAM-1 (O and P, blue) in Ngn1/; Ngn2/ mutant (P and R) or wild-type littermates (O and
Q) at E15.5. SMA cells are associated with larger vessels but are reduced in smaller branched vessels in Ngn1/; Ngn2/ mutants (O
versus P, Q versus R, arrows). Scale bars are 100 m.
such as CX40, NP1, and ephrinB2 was greatly reduced in arterial differentiation, or whether they actually direct the
patterning of vascular remodeling and arteriogenesis.Ngn1, 2 double mutant embryos (Figures 4E–4N, arrows;
see Supplemental Figures S2A and S2B at http://www. Because there is no clear anatomical frame of reference
to compare the pattern of blood vessel branching in thecell.com/cgi/content/full/109/6/693/DC1). This reduc-
tion of arterial marker expression was most apparent in complete absence of peripheral nerves, we sought a
mutation that disrupted the organization of peripheralsmaller-diameter vessels (5–15m), while larger-diame-
ter vessels (30–100 m) appeared unaffected (Supple- nerves without completely eliminating them.
Such a phenotype is caused by a mutation in themental Figure S2B, arrows). In addition, there appeared
to be a loss of SMA cells (or lack of SMA expression) Semaphorin3A gene (Sema3A), which encodes an axon
guidance molecule (reviewed in Kolodkin, 1998). Inin smaller vessels in the mutant embryos (Figure 4O
versus 4P, Figure 4Q versus 4R, arrows). Taken together, Sema3A mutants, the pattern of peripheral nerve growth
is disorganized (Taniguchi et al., 1997; see Supplementalthese data suggest that arteriogenesis, particularly of
smaller-diameter vessels, is deficient in mouse limbs Figures S3A, S3B, S3D and S3E), and the axons appear
more fasciculated and less finely branched (Figure 5Alacking peripheral nerves.
versus 5B, 2H3 staining [green]). Strikingly, despite this
disorganization, smaller-diameter blood vessels wereNerves Direct the Patterning of Vascular
Remodeling and Arteriogenesis still aligned with the disorganized peripheral nerves in
Sema3A/ limb skin at E15.5 (Figures 5B and 5E, arrowsThe preceding observations raised the question of
whether peripheral nerves are simply required for proper and open arrowheads). In addition, these nerve-associ-
Cell
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Figure 5. Peripheral Nerves Pattern Arte-
riogenesis and Blood Vessel Branching in an
erbB3-Dependent Manner
(A–F) Whole-mount triple immunofluores-
cence confocal microscopy was performed
with antibodies to BFABP (D–F, red) in addi-
tion to PECAM-1 (A–F, blue, arrows) and 2H3
(A–C, green, open arrowheads) in Sema3A/
homozygous mutants (B and E), erbB3/ ho-
mozygous mutants (C and F), or wild-type
littermates (A and D) at E15.5. Sema3A/ mu-
tants contain a normal complement of
BFABP Schwann cells (D versus E) while
erbB3 mutants lack them completely (F). Ar-
teries are still aligned with disorganized
nerves in Sema3A/ mutants (B and E,
arrows and open arrowheads) but not in
erbB3/ mutants (C and F, arrows and open
arrowheads).
(G–L) Triple labeling with CX40 (G–L, red,
arrows), PECAM-1 (G–I, blue), and 2H3 (G–I,
green, open arrowheads) in Sema3A/ mu-
tants (H and K), erbB3/ mutants (I and L),
or wild-type littermates (G and J) at E15.5.
The expression of CX40 was downregulated
in erbB3/ mutants (J and K versus L,
arrows). Similar results were obtained with
NP1 (not shown). Note that the nerves of
erbB3/ mutants are not as tightly bundled
as those in wild-type and Sema3A/ mutants.
(M–R) Triple labeling with SMA (M–R, red,
arrows), PECAM-1 (M–O, blue), and 2H3
(M–R, green, open arrowheads) in Sema3A/
mutants (N and Q), erbB3/ mutants (O and
R), or wild-type littermates (M and P) at E15.5.
SMA cell association is observed around
large vessels but in fewer of the smaller
branched vessels in erbB3/ mutants as
compared to wild-type and Sema3A/ mu-
tants (M and N versus O, P and Q versus R,
red, arrows). Relative scale bars are shown
in (A)–(C), (G)–(I), and (M)–(O). Scale bars are
100 m.
ated vessels still expressed arterial markers such as a requirement for axons, their associated Schwann cells,
or both. This could not be determined in Sema3A/Cx40 (Figures 5H and 5K, arrows and open arrowheads)
and NP1 (data not shown) and were covered withSMA mice, because Schwann cells remain associated with
peripheral nerves in this mutant (Figures 5D and 5E;cells (Figures 5N and 5Q, arrows and open arrowheads).
These data suggest that peripheral nerves are not simply BFABP). To address this question, we used erbB3/
mice. ErbB3 is a coreceptor for the axon-derived signalnecessary for arteriogenesis but also direct the pat-
terning of arterial differentiation and vascular remodel- Neuregulin-1, which is expressed by Schwann cells and
ing in limb skin. is essential for their development and survival (reviewed
in Garratt et al., 2000). In erbB3/ mice (Riethmacher
et al., 1997), there is a complete absence of peripheralSchwann Cells Are Required for Arterial Differentiation
and Blood Vessel-Nerve Alignment nerve-associated Schwann cells (Figure 5D versus 5F;
BFABP), and the pattern of axon growth is disorganizedA question raised by the foregoing observations is
whether the nerve dependence of arteriogenesis reflects (Figure 5A versus 5C; 2H3, open arrowheads; see Sup-
Patterning of Arteriogenesis by Peripheral Nerve
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plemental Figures S3C and S3F at http://www.cell.com/ We first examined the expression of VEGF in the limb
skin using anti-VEGF antibodies. Double-labeling withcgi/content/full/109/6/693/DC1).
In contrast to Sema3A mutants, association of blood antibodies to VEGF and the neuron-specific marker III
tubulin (TuJ1) revealed that the growth factor was ex-vessels with peripheral nerves was greatly reduced in
erbB3/ limb skin at E15.5 (Figure 5A versus 5C, arrows pressed in nerves at a relatively higher level than in
surrounding mesenchymal tissue (Figures 6A and 6B,and open arrowheads). To quantify this, we measured
the fractional length of nerve fibers associated with arrows versus open arrowheads). To confirm the expres-
sion of VEGF in peripheral nerve by an independentblood vessels. There was no statistically significant dif-
ference in this parameter between Sema3A/ mutants method and to analyze the contribution of neurons and
Schwann cells to this expression, we performed RT-(95.4%  4.0%) and wild-type littermates (89.7% 
4.1%) (see Supplemental Figure S3G at http://www.cell. PCR experiments on acutely isolated peripheral neurons
and glia. Sensory neurons isolated from E14.5 dorsalcom/cgi/content/full/109/6/693/DC1). In contrast, the
amount of alignment was greatly reduced in erbB3/ root sensory ganglia (DRG) by FACS using the lectin IB4
expressed the 120, 144, and 164 but not the 188 isoformsmutants (14.9%  12.0%). In addition, there was a clear
reduction in the expression of the arterial markers CX40 of VEGF (Figure 6D, in vivo). By contrast, Schwann cells
isolated from limb skin by FACS using anti-p75LNTR at(Figures 5G and 5J versus 5I and 5L, arrows), NP1 (data
not shown), and ephrinB2 (see Supplemental Figure the same age expressed only the 120 isoform of VEGF
(Figure 6D, in vivo). These results indicate that bothS2C) in erbB3/ mutants, like that in Ngn1, 2 double
mutants (cf. Figures 4G and 4H), though somewhat less sensory neurons and glia contribute to the expression
of multiple isoforms of VEGF in peripheral nerves in vivo.severe. Similarly, there was a pronounced but less ex-
tensive deficiency of SMA cells associated with
smaller-diameter blood vessels in erbB3/ mice (Fig- VEGF Induces Arterial Differentiation In Vitro
ures 5M and 5P versus 5O and 5R, arrows). Similar We next examined whether VEGF can induce arterial
results were obtained in erbB2 mutant embryos in which marker expression in isolated primary embryonic endo-
the early cardiac defect is genetically rescued by an thelial cells in vitro. To do this, we isolated ephrinB2-
 myosin heavy-chain (-MHC) promoter-driven erbB2 negative endothelial cells from E10.5 ephrinB2taulacZ/
cDNA (data not shown), embryos which exhibit a similar heterozygous embryos by two color FACS, using anti-
peripheral nerve phenotype as do those lacking erbB3 PECAM-1 antibody and a fluorescent -galactosidase
(Morris et al., 1999). substrate, FDG (Nolan et al., 1988), and gating on the
These data suggest that both the patterning of vascu- PECAM-1, lacZ population (Figure 6E, left, R1). Cyto-
lar remodeling along peripheral nerves and the induction spin analysis of the sorted cells performed directly after
of arterial differentiation are defective in erbB3/ mice FACS confirmed that freshly isolated cells from the R1
and are associated with a lack of Schwann cells in pe- fraction did not express -galactosidase as detected
ripheral nerve. The absence of Schwann cells may cause by X-gal staining (Figure 6E, right, R1 versus R2) but
this vascular defect, or the defect may instead reflect were positive for PECAM-1 (data not shown).
an autonomous requirement for erbB3 function in endo- To determine whether VEGF can induce ephrinB2 ex-
thelial cells. As a first step to addressing this issue, we pression, we cultured the isolated ephrinB2-negative
examined the expression of erbB family members in endothelial cells (Figure 6E, R1) for 2 days on collagen
limb endothelial cells. PECAM-1-positive endothelial type IV-coated plates in the presence of basic FGF
cells were isolated from E15.5 limb skin by fluorescence- (bFGF) to support survival. Under these conditions, only
activated cell sorting (FACS) and were analyzed for ex- 10% of endothelial cells spontaneously expressed
pression of erbB2, erbB3, and erbB4 mRNAs by RT- ephrinB2 (Figure 6F, left). By contrast, both VEGF120 and
PCR. No erbB3 or erbB4 and only very weak erbB2 VEGF164 strongly enhanced ephrinB2 expression, by 4-
expression were detectable in these isolated endothelial to 5-fold over control, at concentrations as low as 2.5 pM
cells (data not shown). These data suggest that the re- (Figure 6F, left). However, the proportion of ephrinB2-
quirement for erbB3 in peripheral arterial differentiation positive cells never exceeded 50% even at higher con-
is unlikely to reflect an autonomous requirement in endo- centrations of VEGF. Increased expression of NP1 and
thelial cells, and more likely reflects the absence of CX40 was also detected by immunohistochemical stain-
Schwann cells. Confirmation of this will, however, re- ing (data not shown). We also tested a number of other
quire a specific knockout of this gene in Schwann cells. candidate growth factors for their ability to promote
ephrinB2 expression. BMP2, PDGF, IGF-I, NGF, NT-3,
BDNF, GGF, and Sonic Hedgehog (Shh), like bFGF, didVEGF Is Expressed in Peripheral Nerves
We next sought to identify candidate signals that might not substantially upregulate the arterial marker at any
concentration tested (data not shown). However, TGF1mediate the influence of peripheral nerves on arteriogen-
esis in order to determine whether these signals are and Activin-A did increase expression of ephrinB2 to a
similar extent as did VEGF, but only at concentrationsprovided by Schwann cells or are provided by axons in
a Schwann cell-dependent manner. We initially focused two orders of magnitude higher than the minimum effec-
tive dose of VEGF (250 versus 2.5 pM, respectively).on vascular endothelial growth factor (VEGF) because
it is known to be involved in a number of different as- Soluble VEGFR2(Flk1)-Fc, a potent VEGF antagonist (re-
viewed in Ferrara and Davis-Smyth, 1997), blockedpects of blood vessel development, including both vas-
culogenesis and angiogenesis in vivo (Carmeliet et al., VEGF- but not TGF1-mediated induction of ephrinB2,
while conversely anti-TGF antibody blocked the TGF11996; reviewed in Ferrara, 2000; Ferrara et al., 1996;
Fong et al., 1995; Shalaby et al., 1995). but not the VEGF effect (see Supplemental Figures S4A
Cell
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and S4C at http://www.cell.com/cgi/content/full/109/6/
693/DC1).
It was important to distinguish whether VEGF in-
creased the proportion of ephrinB2-positive cells by se-
lection or by induction of expression. Although the two
VEGF isoforms tested each promoted cell proliferation
and/or survival at higher concentrations (Figure 6F,
right), at the lowest concentration that induced ephrinB2
expression there was no net change in total cell number,
while the percentage of ephrinB2-positive cells was in-
creased about 5-fold (Figure 6F, 2.5 pM, left versus
right). This lack of a change in net cell number did not
reflect increased proliferation balanced by increased
cell death, because only 5% of the cells died in the
presence or absence of VEGF under these conditions
(data not shown). Finally, at high concentrations of VEGF
that caused a 2-fold increase in cell number (250 pM),
there was no further increase in the proportion of
ephrinB2-positive cells (Figure 6F, 250 pM). Taken to-
gether, these data suggest that the increase in the pro-
portion of ephrinB2-positive cells caused by VEGF164/120
cannot be explained by increased cell survival or cell
proliferation, but rather reflects induction of expression.
Neurons and Schwann Cells Induce EphrinB2
Expression via VEGF In Vitro
The expression of VEGF in peripheral nerve, the require-
ment of the nerve for arteriogenesis in vivo, and the
ability of VEGF to induce ephrinB2 expression in vitro
together suggested that neurons and/or Schwann cells
might induce ephrinB2 expression via VEGF. To directly
test this, we cocultured isolated ephrinB2-negative en-
dothelial cells with purified DRG sensory neurons or
Schwann cells (see Experimental Procedures). The pu-
rity of these neuronal or glial cultures was over 95% as
assessed by immunostaining for the glial marker GFAP
and the neuronal marker peripherin (Figures 7A–7D),
consistent with RT-PCR analysis of neuronal and glial
marker mRNAs (Figure 6D, in vitro, GFAP and SCG10).
The cultured sensory neurons expressed a similar com-
Figure 6. VEGF Is Expressed in Peripheral Nerve and Induces Arte-
plement of VEGF isoforms as they did in vivo, except thatrial Differentiation In Vitro
VEGF188 was weakly expressed (Figure 6D). However,
(A–C) VEGF expression in embryonic limb skin at E14.5. Whole-
although freshly isolated Schwann cells expressed onlymount double immunofluorescence confocal microscopy was per-
VEGF120, when they were cultured in the absence offormed with antibodies to VEGF (A and B, red) and the neuron-
specific marker III tubulin (TuJ1) (A and C, green). Note that VEGF neurons they expressed the same VEGF isoforms as did
is highly expressed in nerves (A–C, arrows) as compared to its DRG neurons (Figure 6D, in vitro). The induction of other
expression in surrounding cells (A and B, open arrowheads). Scale VEGF isoforms in these cultured glia may be caused
bars, 100 m. either by factors in the culture medium or by the removal
(D) RT-PCR analysis of VEGF-A isoforms (VEGF-188, -164, -144,
of an inhibitory influence normally exerted on Schwannand -120) expression in freshly isolated IB4 lectin DRG neurons
cells by axons in vivo.and P75 limb skin Schwann cells (in vivo), and in primary DRG
neurons and sciatic nerve-derived Schwann cells (in vitro). The When such purified Schwann cells or sensory neurons
acutely isolated DRG neurons express VEGF-164, -144, and -120, were cocultured for 2 days with isolated ephrinB2-nega-
whereas the Schwann cells express only VEGF-120. In contrast, tive endothelial cells, both neural cell types induced
both cultured DRG neurons and Schwann cells express all isoforms endothelial ephrinB2 expression in 60% of the cells
of VEGF. There is no difference in neuronal VEGF expression under
(Figures 7E and 7G). As was the case for purified VEGF,serum- or nonserum-containing culture conditions. GFAP and
SCG10 were used as Schwann cell and neuronal markers, respec-
tively. Messenger RNA from E14.5 DRG was used as a positive
control.
and were double-stained with X-gal and anti-PECAM antibody. Both(E) FACS profile of cells derived from E10.5 ephrinB2taulacZ/ heterozy-
gous embryos and labeled with anti-PECAM-PE antibody and FACS- the percentage of ECs expressing ephrinB2-lacZ (left) and the total
number of ECs (right) were measured. Bars represent mean SEM.gal. PECAM, ephrinB2 (R1) and PECAM, ephrinB2 (R2) sorted
cells were stained using X-gal immediately after isolation (right). Note that maximal induction of ephrinB2 expression (5-fold) is
achieved at 2.5 pM VEGF120/164, at which concentration there is no(F) PECAM, ephrinB2 endothelial cells (ECs) (E, fraction R1) were
cultured in various concentrations of VEGF120 or VEGF164 for 2 days, net change in the total number of ECs.
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7H). Soluble VEGFR2 (Flk1)-Fc protein was able to block
this induction (Figures 7E–7H), suggesting that the effect
of both neural cell types on ephrinB2 expression is medi-
ated by VEGF (Figure 6D, in vitro). In contrast, anti-TGF
antibody had no effect (data not shown). These data
indicate that neurons and Schwann cells can induce
ephrinB2 in primary embryonic endothelial cells in vitro
and that they do so through secretion of one or more
isoforms of VEGF.
Schwann Cells Are Required for VEGF Expression
in Peripheral Nerves
The foregoing data provided evidence that peripheral
nerves can induce arterial marker expression in cultured
endothelial cells via local secretion of VEGF. As a first
step toward testing this hypothesis in vivo, we asked
whether VEGF expression in peripheral nerve was af-
fected in erbB3/ mutants. As shown earlier, in these
mutants peripheral nerves are present in the skin, but
blood vessels do not remodel in association with them
or express arterial markers. Strikingly, in erbB3/ limbs
at E15.5, little or no VEGF expression was detected in
peripheral nerves (Figures 8A, 8D, and 8G versus 8C,
8F, and 8I, arrows). However, VEGF expression in sur-
rounding nonneural tissues appeared unaffected (Fig-
ures 8A and 8D versus 8C and 8F, open arrowheads).
By contrast, nerve bundles of similar size expressed
VEGF in Sema3A/ embryos, in which nerve-associated
vascular remodeling and arterial differentiation do occur
(Figures 8B, 8E, and 8H, arrows). These data indicate
that the absence of Schwann cells and arteriogenesis
in erbB3/ mutants is correlated with a specific reduc-
tion in nerve-associated VEGF expression. In contrast,
in Sema3A/ mutant where peripheral nerves are disor-
ganized but Schwann cells are present, VEGF expres-
sion in the nerve is maintained and nerve-associated
endothelial cell remodeling and arterial differentiation
also occurred.
Figure 7. Purified Sensory Neurons or Schwann Cells Promote Arte-
rial Differentiation In Vitro via VEGF Discussion
(A–D) Primary cultures of sciatic nerve-derived Schwann cells or
DRG neurons were triple-labeled with antibodies to the Schwann cell
Peripheral nerves are known to associate with subsetsmarker GFAP (A and B, green) and the neuronal marker peripherin (A
of blood vessels (Martin and Lewis, 1989), but the signifi-and B, red) in combination with the nuclear dye To-Pro-3 (A–D,
cance of this association for vascular development hasblue). More than 95% of the cells in these cultures were GFAP,
peripherin Schwann cells or peripherin, GFAP neurons, respec- been unclear. Using several recently described artery-
tively. The same culture preparations were used for RT-PCR analysis specific markers, we now show that arterial blood ves-
(Figure 6D, in vitro). sels are specifically aligned with peripheral sensory
(E–H) PECAM, ephrinB2 endothelial cells were cocultured with
nerves in embryonic limb skin. Several lines of evidenceDRG neurons or sciatic nerve-derived Schwann cells (A–D) for 2 days
suggest that this association reflects a requirement forin the presence or absence of Flk1-Fc (soluble VEGFR2) protein, and
the nerve to induce arterial differentiation. First, in mu-were double-stained with X-gal and anti-PECAM antibody. Quantifi-
cation was performed as in Figure 6. Note that both neurons and tants lacking peripheral sensory axons and/or Schwann
Schwann cells promote ephrinB2 expression to a similar extent as cells, arterial differentiation does not occur and remod-
did VEGF (Figure 6), without changing total EC number. The effect eling appears abnormal. Second, in mutants containing
of the neural cells is blocked by Flk1-Fc and is therefore VEGF
disorganized peripheral nerve fibers, arteries continuedependent. Bars represent mean  SEM. Asterisk (E and G) indi-
to follow the altered nerve branching patterns. Third,cates statistically significant difference (p  0.05) according to Stu-
purified peripheral sensory neurons or Schwann cellsdent’s t test.
can induce arterial marker expression in cultured endo-
thelial cells. The fact that this induction can be blocked
by a specific VEGF antagonist and mimicked by purifiedthis increase in ephrinB2 expression reflected induction
and not simply increased cell survival or proliferation, VEGF120 or VEGF164, taken together with the relatively
high level of VEGF expression in peripheral nerve in vivo,since the total number of endothelial cells did not in-
crease appreciably in these cocultures (Figures 7F and further suggests that the effect of the nerve to promote
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Figure 8. Requirement of erbB3 for Neuronal
VEGF Expression
Whole-mount double immunofluorescence
confocal microscopy was performed with an-
tibodies to VEGF (A–F, red) and peripherin
(A–C and G–I, green) in Sema3A/ mutants
(B, E, and H), erbB3/ mutants (C, F, and I),
or wild-type littermates (A, D, and G) at E15.5.
No or only weak VEGF expression was de-
tected in nerves in erbB3/ mutants as com-
pared to its expression in wild-type and
Sema3A/ mutants (A and B versus C, D and
E versus F, arrows). VEGF expression in non-
neural elements was retained in erbB3/ mu-
tants (D–F, open arrowheads and data not
shown). The reduction of VEGF expression
in peripheral nerves of erbB3/ embryos is
correlated with the absence of Schwann cells
from these nerves (cf. Figures 5D and 5F).
Scale bars are 100 m.
arteriogenesis may be mediated by local secretion of the principal source of VEGF, or that axons are the princi-
pal source but their expression of the growth factorVEGF.
requires the presence of Schwann cells. In support of the
latter explanation, sensory neurons express a greaterArterial Differentiation Occurs in Association
diversity of VEGF isoforms in vivo than do Schwannwith Peripheral Nerves
cells. Resolution of this issue, as well as a direct demon-The use of arterial markers has revealed that blood ves-
stration that nerve-derived VEGF is required for arterialsel-nerve association in the skin is not random but re-
differentiation in vivo, will require sensory neuron- andflects an invariant alignment of arterial vessels with
Schwann cell-specific knockouts of VEGF.nerves. Our genetic data indicate that this nerve associa-
Although VEGF expression is detected in nerves at ation is essential for the differentiation of arteries and
higher level than in surrounding tissue, the growth factorguides the patterning of arteriogenesis. Consistent with
is nevertheless expressed by such nonneural elementsthe chick studies (Martin and Lewis, 1989), we observe
in the skin. This fact may explain why some remodeling,that the arterial differentiation of the major, large-diame-
and weak expression of arterial markers, occurs eventer vessels in the skin is relatively less affected by the
in the absence of nerves or Schwann cells. Similarly,absence of nerves. Nevertheless, it remains unclear
the fact that VEGF is also expressed at relatively higherwhether the subset of vessels whose arterial differentia-
levels by larger-diameter arteries may explain why thetion is nerve dependent is selected simply by proximity
expression of arterial markers by these vessels seemsor is rather prespecified prior to nerve association. In
less affected by the absence of nerves. In the presenceother systems such as the yolk sac and tumor vessels,
of nerves, however, local secretion of VEGF by thearterial differentiation occurs in the absence of any in-
nerves may act to pattern the arterial differentiation ofnervation. Thus, association with nerves is not a general
the smaller-diameter vessels. Whether this VEGF actsrequirement for arterial differentiation. However, similar
via a concentration gradient or is immobilized via thesignals as released by the nerve to promote arterial
extracellular matrix remains to be determined.differentiation in the limb could be provided by other
tissues in different developmental contexts.
VEGF as a Candidate Arterial
Differentiation FactorPeripheral Nerves Promote Arterial Marker
Expression via VEGF We find that VEGF164 and VEGF120 are sufficient to pro-
mote expression of arterial markers in isolated primaryThe data presented here suggest that peripheral nerves
may promote blood vessel association and arteriogene- embryonic endothelial cells in vitro. The vivo relevance
of this observation is supported by the correlative ge-sis by local secretion of VEGF in vivo. The in vitro data
suggest that this growth factor could be provided by netic data presented here, as well as by the recent ob-
servation that mutant mice lacking the 164 and 120, butaxons, by Schwann cells, or by both. In erbB3/ em-
bryos, which lack Schwann cells but not sensory axons not the 188, isoforms of VEGF show defects in ephrinB2
expression in retinal vessels vivo (Stalmans et al., 2002).at E15.5, expression of VEGF in peripheral nerve is
greatly attenuated, and expression of arterial markers Recent work has implicated Alk-1, a receptor for certain
TGF superfamily ligands (Urness et al., 2000), as adoes not occur in association with such axons. These
data suggest either that Schwann cells themselves are potential determinant of arterial identity in vivo in mouse.
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Indeed, we observed that TGF and Activin-A are able signaling between nerves and blood vessels during de-
velopment may serve to orchestrate their mutually de-to induce arterial differentiation in vitro at high concen-
trations. Importantly, however, the effect of isolated pendent functions in both space and time. More gener-
ally, our results raise the possibility that there may beneurons or Schwann cells to induce ephrinB2 expres-
sion was not blocked by a neutralizing anti-TGF anti- organotypic patterns of arterial branching in various tis-
sues, which are adapted to their unique physiology. Ifbody. Notch-Delta signaling has also recently been im-
plicated in the choice between arterial and venous fates so, then local signals provided by organized tissue sub-
components, such as nerve fibers or other structures,in zebrafish (Lawson et al., 2001; Zhong et al., 2001;
reviewed in Thurston and Yancopoulos, 2001. Whether may provide a template to pattern arteriogenesis in
these organs.it is involved in the induction of arterial differentiation
by VEGF remains to be determined.
Experimental ProceduresInterestingly, the proportion of endothelial cells that
expressed ephrinB2 in vitro, even at the highest concen-
Whole-Mount Immunohistochemistry of Limb Skintration of VEGF tested, was never more than 50%. The
Staining was performed essentially as described previously (Gerety
same was true when ephrinB2 was induced by coculture et al., 1999; Wang et al., 1998). Details of the procedure are available
with neurons or Schwann cells. One interpretation of in the Supplemental Experimental Procedures at http://www.cell.
com/cgi/content/full/109/6/693/DC1).these observations is that the ephrinB2-negative popu-
lation isolated for these experiments may be heteroge-
Whole-Mount In Situ Hybridizationneous and consist of both determined but undifferenti-
Whole-mount in situ hybridization was carried out essentially asated arterial precursors as well as other cells not yet
described previously (Wang et al., 1998). E15.5 limbs were hybrid-determined for an arterial fate, in roughly equal propor-
ized with a cRNA probe against the ephrinB2 extracellular domain.
tions. If so, then VEGF might suffice to trigger overt
arterial differentiation in the former, but not the latter, LacZ and Immunohistochemistry in Culture
endothelial cells. Indeed, recent lineage-tracing studies Staining was performed essentially as described previously (Gerety
et al., 1999; Wang et al., 1998). Details of the procedure are availablein zebrafish have revealed that angioblasts are at least
in the Supplemental Experimental Procedures.specified for (although not necessarily committed to)
arterial or venous identities prior to vasculogenesis of
Flow Cytometrythe dorsal aorta and cardinal veins (Zhong et al., 2001).
To isolate ephrinB2-negative endothelial cells, E10.5 embryos wereIn that scenario, VEGF would be a permissive inducing
dissociated by digestion with type 3 collagenase (Worthington) and
signal rather than an instructive determinant of arterial deoxyribonuclease type 1 (DNase 1; Sigma). The cells were labeled
identity. Alternatively, VEGF might indeed be an instruc- with PE-conjugated anti-PECAM antibody (BD Pharmingen) and
then loaded with fluorescein di--D-galactoside (FDG) by osmotictive arterial determinant, but the proportion of cells ex-
shock (1 min at 37	C) according to the manufacturer’s instructionspressing ephrinB2 in response to VEGF might be limited
(Molecular Probe). All sorts and analyses were performed on a FACSby local cell-cell interactions occurring within our cul-
Vantage dual laser flow cytometer (BD Biosciences). Details of thetures.
procedure are available in the Supplemental Experimental Proce-
dures.
Local Control of Vascular Patterning
Why should peripheral nerves direct the differentiation Gene-Specific RT-PCR Analysis
Total RNA was isolated from whole E14.5 DRGs and FACS-isolatedof arteries and the pattern of angiogenic remodeling?
cells from E14.5 DRGs or limb skin, as well as from cultured DRGIn addition to supplying oxygen and nutrients, arterial
neurons and sciatic nerve-derived Schwann cells using the Microvessels express neurotrophic factors such as NGF
RNA Isolation Kit (Stratagene), digested with DNase 1 (GIBCO-BRL)
(Scarisbrick et al., 1993), NT3 (Francis et al., 1999), and and reverse-transcribed with Superscript First-Strand Synthesis
BDNF (Donovan et al., 2000). The expression of such System for RT-PCR (GIBCO-BRL). VEGF, GFAP, SCG10, and Hprt
genes were amplified using PLATINUM Taq DNA polymeraseneurotrophic factors in blood vessels is thought to be
(GIBCO-BRL) for 45 cycles. The PCR products were fractionatedimportant to maintain the survival of growing axons be-
by electrophoresis. The sequences of the PCR primers are availablefore they arrive at their peripheral targets, which provide
in the Supplemental Experimental Procedures at http://www.cell.an independent source of neurotrophins (reviewed in
com/cgi/content/full/109/6/693/DC1.
Lewin and Barde, 1996). Thus, nerves may promote
blood vessel association and arterial differentiation Culture Methods
shortly after their arrival in the periphery in order to Primary embryonic mouse endothelial cells isolated by FACS were
cultured on poly-D-lysine- (Biomedical Technologies Inc), laminin-ensure access to a local source of survival factors during
(BD Biosciences), and collagen type IV-coated plates (BD Biosci-subsequent growth.
ences). The culture medium contained EMB-2 (Clonetics) with 15%The ontogenetic interdependence of arteries and
FBS (Hyclone Laboratories), Penicillin/Streptomycin (BioWhittaker),nerves also makes sense in terms of the later functional
and 10 ng/ml bFGF (R&D). VEGF120, VEGF164, TGF1, IGF1, PDGF,
interactions between the nervous and circulatory sys- NT3, BDNF, Activin-A, Flk1-Fc, Flt1-Fc, and anti-TGF blocking anti-
tems. For example, peripheral autonomic nerves release body were purchased from R&D. BMP2 was a gift from the Genentics
Institute. Rat Schwann cells were isolated from sciatic nerves of P0catecholamines to activate -adrenergic receptors on
neonatal rats as described (Brockes et al., 1979). Rat sensory neu-arterial smooth muscle cells (Zukowska-Grojec et al.,
rons were isolated from DRG of E14.5–E16.5 rat embryos as de-1993), while sensory nerves regulate injury-induced in-
scribed (Murphy et al., 1996). Most cultures were incubated for 2flammation through the release of neuropeptides (re-
days in a reduced oxygen environment to more closely approximate
viewed in Baluk, 1997). An early association between physiological oxygen levels (Studer et al., 2000). Similar results were
arteries and axons could facilitate the later development observed under standard conditions (see Supplemental Figures S5E
and S5F at http://www.cell.com/cgi/content/full/109/6/693/DC1).of such functional interactions. In this way, reciprocal
Cell
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Details of the procedure are available in the Supplemental Experi- Garratt, A.N., Britsch, S., and Birchmeier, C. (2000). Neuregulin, a
factor with many functions in the life of a schwann cell. Bioessaysmental Procedures.
22, 987–996.
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